I think that for many investors the worry may be that this reformulation of the formulation will drag on interminably.. It is my immediate concern anyway... Does anyone else read this differently?.
"PharmAust is now in a position to formulate monepantel for its trials by fine tuning the drugdosage form"...
Ann: Monepantel Principal Metabolite Shows Anti-Cancer Activity, page-31
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.015(6.98%) |
Mkt cap ! $82.69M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $475.3K | 2.128M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 93524 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 71004 | 2 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable
